Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP2 | P42575 | 1/20 | 1.00 |
| ▸ | NAAA | Q02083 | 1/20 | 0.77 |
| ▸ | FAAH | O00519 | 5/20 | 0.66 |
| ▸ | EPHX1 | P07099 | 5/20 | 0.64 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.61 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3839655 | 1.00 | CASP2 (1.00) | CASP2NAAAFAAHEPHX1DNM1 | |
| SCHEMBL2497062 | 1.00 | CASP2 (1.00) | CASP2NAAAFAAHEPHX1DNM1 | |
| SCHEMBL12847246 | 1.00 | CASP2 (1.00) | CASP2NAAAFAAHEPHX1DNM1 | |
| SCHEMBL10149806 | 1.00 | CASP2 (1.00) | CASP2NAAAFAAHEPHX1DNM1 | |
| SCHEMBL9288380 | 1.00 | CASP2 (1.00) | CASP2NAAAFAAHEPHX1DNM1 | |
| SCHEMBL10149803 | 1.00 | CASP2 (1.00) | CASP2NAAAFAAHEPHX1DNM1 | |
| SCHEMBL12738558 | 1.00 | CASP2 (1.00) | CASP2NAAAFAAHEPHX1DNM1 | |
| SCHEMBL5065624 | 1.00 | CASP2 (1.00) | CASP2NAAAFAAHEPHX1DNM1 | |
| SCHEMBL12847247 | 1.00 | CASP2 (1.00) | CASP2NAAAFAAHEPHX1DNM1 | |
| SCHEMBL9795571 | 1.00 | CASP2 (1.00) | CASP2NAAAFAAHEPHX1DNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109562094-A | Compositions and methods for enhancing antimicrobial agents | 希拉匹克斯生物科学有限公司 | 2019-04-02 | — | — | CN | claimed |
| CN-107530317-A | Combination of cannabinoids and N-acylethanolamines | 希拉匹克斯生物科学有限公司 | 2018-01-02 | — | — | CN | claimed |
| CN-109562094-A | Compositions and methods for enhancing antimicrobial agents | 希拉匹克斯生物科学有限公司 | 2019-04-02 | — | — | CN | disclosed |
| CN-107613966-A | Combination of opioids and N-acylethanolamines | 希拉匹克斯生物科学有限公司 | 2018-01-19 | — | — | CN | disclosed |
| CN-107530317-A | Combination of cannabinoids and N-acylethanolamines | 希拉匹克斯生物科学有限公司 | 2018-01-02 | — | — | CN | disclosed |
| US-20160009657-A1 | AMINE-CONTAINING LIPIDS AND USES THEREOF | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2016-01-14 | — | — | US | disclosed |
| US-9006487-B2 | Amine-containing lipids and uses thereof | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2015-04-14 | — | — | US | disclosed |
| US-20120009222-A1 | MODULATION OF THE IMMUNE RESPONSE | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2012-01-12 | — | — | US | disclosed |
| US-20110052673-A1 | THERAPEUTIC COMPOSITIONS | SHIRE HUMAN GENETIC THERAPIES, INC. | 2011-03-03 | — | — | US | disclosed |
| US-20110009641-A1 | Amine-containing lipids and uses thereof | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2011-01-13 | — | — | US | disclosed |
| WO-2010062322-A2 | MODULATION OF THE IMMUNE RESPONSE | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2010-06-03 | — | — | WO | disclosed |
| US-6117562-A | A THERMAL IMAGE TRANSFER INK LAYER FORMED ON THE SUPPORT; INK LAYER COMPRISING A COLORING AGENT, A RESIN AND A PLASTICIZER FOR LOWERING THE MELT VISCOSITY OF RESIN | RICOH COMPANY, LTD. (JP) | 2000-09-12 | — | — | US | disclosed |
| US-5716477-A | CONSISTS OF A SUPPORT AND THERMAL IMAGE TRANSFER INK LAYER FORMED ON SAID SUPPORT CONSISTS OF A COLORING AGENT AND A PLASTICIZER FOR LOWERING MELT VISCOSITY OF THE RESIN, HIGH THERMOSENSITIVITY ON CLOTH, PLASTIC, OR PAPER RECEIVER | RICOH COMPANY, LTD. (JP) | 1998-02-10 | — | — | US | disclosed |
| US-4575734-A | LEVCO DYES | RICOH COMPANY, LTD. (JP) | 1986-03-11 | — | — | US | disclosed |
| US-4562448-A | Heat-sensitive transfer medium | RICOH CO., LTD. (JP) | 1985-12-31 | — | — | US | disclosed |
| US-4547788-A | SHEET HAVING LAYER CONTAINING LEVCO DYE; ACCEPTOR SHEET CONTAININGCOLORING AGENT; POROUS FILLER | RICOH COMPANY, LTD. (JP) | 1985-10-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120009222-A1 | MODULATION OF THE IMMUNE RESPONSE | FCGRT, MYD88, C3AR1 | CASP2 2840/4885NAAA 789/4885FAAH 858/4885 |
| US-20110052673-A1 | THERAPEUTIC COMPOSITIONS | PHOSPHO1, SGMS1, APOB | CASP2 1497/4885NAAA 625/4885FAAH 801/4885 |
| US-20110009641-A1 | Amine-containing lipids and uses thereof | PHOSPHO1, CHMP4B, SGMS1 | CASP2 3638/4885NAAA 78/4885FAAH 412/4885 |
| US-20160009657-A1 | AMINE-CONTAINING LIPIDS AND USES THEREOF | PHOSPHO1, CHMP4B, SGMS1 | CASP2 3638/4885NAAA 78/4885FAAH 412/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.